HomeCompareBNDP vs PFE

BNDP vs PFE: Dividend Comparison 2026

BNDP yields 0.95% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $28.5K in total portfolio value· pulled ahead in Year 9
10 years
BNDP
BNDP
● Live price
0.95%
Share price
$74.38
Annual div
$0.70
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$100.78
Full BNDP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BNDP vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNDPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNDP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNDP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNDP
Annual income on $10K today (after 15% tax)
$80.55/yr
After 10yr DRIP, annual income (after tax)
$85.66/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,234.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNDP + PFE for your $10,000?

BNDP: 50%PFE: 50%
100% PFE50/50100% BNDP
Portfolio after 10yr
$35.3K
Annual income
$13,179.75/yr
Blended yield
37.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BNDP
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNDP buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNDPPFE
Forward yield0.95%6.13%
Annual dividend / share$0.70$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$21.0K$49.6K
Annual income after 10y$100.78$26,258.71
Total dividends collected$980.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BNDP vs PFE ($10,000, DRIP)

YearBNDP PortfolioBNDP Income/yrPFE PortfolioPFE Income/yrGap
1$10,795$94.77$9,153$693.39+$1.6KBNDP
2$11,646$95.61$8,593$849.25+$3.1KBNDP
3$12,558$96.40$8,336$1,066.78+$4.2KBNDP
4$13,534$97.15$8,437$1,384.80+$5.1KBNDP
5$14,579$97.85$9,013$1,875.40+$5.6KBNDP
6$15,698$98.51$10,306$2,680.72+$5.4KBNDP
7$16,896$99.13$12,820$4,101.38+$4.1KBNDP
8$18,179$99.72$17,673$6,826.70+$506.00BNDP
9← crossover$19,551$100.27$27,543$12,591.86$8.0KPFE
10$21,021$100.78$49,560$26,258.71$28.5KPFE

BNDP vs PFE: Complete Analysis 2026

BNDPStock

The fund employs an indexing investment approach designed to track the performance of the Bloomberg U.S. Universal Float Adjusted Index, which measures the performance of U.S. dollar-denominated, taxable bonds that are rated either investment-grade or high-yield as determined by the index provider. The target index includes U.S. government and agency obligations, corporate bonds, mortgage-backed securities, asset-backed securities, and emerging market bonds, all denominated in the U.S. dollar and with maturities of at least one year.The Vanguard Core-Plus Bond Index ETF is a stand alone product and is separate and distinct from the Vanguard Core-Plus Bond ETF (VPLS) and the Vanguard Core-Plus Bond Fund (VCPIX and VCPAX). Differences in scale, certain investment processes, and underlying holdings are expected to produce different investment returns by the funds.

Full BNDP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BNDP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNDP vs SCHDBNDP vs JEPIBNDP vs OBNDP vs KOBNDP vs MAINBNDP vs JNJBNDP vs MRKBNDP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.